Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Communications Post-Gottlieb: No Slow-Down In Statements, But Attribution Changes
Apr 29 2019
•
By
Michael McCaughan
The torrid pace of press releases from the US FDA established under former commissioner Scott Gottlieb has continued under Ned Sharpless.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet